DDX53 and neoplasm: This resulted in an increase in the efficacy of RT due to MRTX1257 leading to the achievement of durable responses in immunocompetent mice and the generation of a potent anti-tumor immune memory against both CT26 KRASG12C+/+ and CT26 WT cells.